Tilapia
Vaccines provide Brazil’s fish farmers with a platform for sustainable growth
An interview with Danielle Zanerato Damasceno, Technical and Commercial Manager, PHARMAQ Brazil
Fish health-focused trainings bring growth to Colombian tilapia sector
An innovative project focused on delivering aquaculture skills trainings in Colombia is helping to boost productivity, sustainability and job growth in the country’s burgeoning tilapia sector.
Antibiotic resistance research sounds warning for Vietnamese freshwater aquaculture
High levels of antibiotic resistance have been found in samples of the bacterium Aeromonas hydrophila extracted from farmed freshwater fish as part of a study in Northern Vietnam, underlining the need for more responsible disease management practices in the region.
Vaccine ‘work in progress’ in major aquaculture markets, Part 2: Tilapia
Nile tilapia is now the second most farmed fish worldwide, in part due to its adaptability. It is, however, susceptible to a number of diseases.
Why fish vaccines are increasingly coming in smaller doses
An interview with Dr Bjørn Brudeseth, PhD, PHARMAQ
Taming tilapia lake virus requires improved expert collaboration
Tilapia lake virus (TiLV) is an emerging threat to aquaculture, having been discovered in 2014 and now reported in 16 countries.
- « Previous
- 1
- 2
- 3
